Germline sequence variants and prostate-specific antigen interpretation

Clinical Chemistry

Volumn 57, Issue 5, 2011, Pages 662-663

  Loeb, Stacy ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER DIAGNOSIS; CANCER RISK; GENE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; GERMLINE MICRONUCLEUS; HUMAN; PROSTATE BIOPSY; PROSTATE CANCER; SEQUENCE ANALYSIS; SHORT SURVEY;

AGE OF ONSET; GENETIC LOCI; GENETIC MARKERS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 79956109375     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.161869     Document Type: Short Survey

References (5)

1. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995;154:407-13.
2. Klein LT, Lowe FC. The effects of prostatic manipulation on prostate-specific antigen levels. Urol Clin North Am 1997;24:293-7. (Pubitemid 27169253)
3. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008;40:316-21. (Pubitemid 351311772)
4. Loeb S, Carter HB, Walsh PC, Isaacs WB, Kettermann A, Tanaka T, et al. Single nucleotide polymorphisms and the likelihood of prostate cancer at a given prostate specific antigen level. J Urol 2009;182:101-4; discussion 105.
5. Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson I, Arinbjarnarson S, et al. Genetic correction of PSA values using sequence variants associated with PSA levels. Sci Transl Med 2010;2:62ra92.